TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Control Trial Assessing the Effects of an Intermediate Care Package in Preventing Hospitalisation of Elderly Patients With Chronic Obstructive Pulmonary Disease (COPD)
Brief Summary: Chronic obstructive pulmonary disease (COPD) is a term used for the conditions of chronic bronchitis and emphysema, diseases that are very common among the elderly and diseases that account for up to15% of all general medical admissions to National Health Service Hospitals. In a recent report on emergency admissions to acute hospitals in London, the King's Fund concluded that taking better care of elderly patients with COPD could reduce pressures on acute hospitals, and suggested that identification of vulnerable patients with lung disease and "pro-active," rather than "reactive," management might reduce the chances of hospitalisation. In this study, the investigators wish to compare a group of patients with COPD who are managed in the normal way, with another group of patients with COPD who receive all interventions known to be of some benefit to those with this condition. This will include a pulmonary rehabilitation programme, intensive education regarding self care, targeted advice to their general practitioners regarding how best to manage COPD, and regular contact with specialist respiratory nurses who will support the patients in their own homes by a combination of home visits and telephone contact. The value of such a comprehensive intervention will be studied, in terms of both its ability to reduce admissions to the hospital and its impact on quality of life.


Options:
A: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Other: breathing retraining, Other: exercise training | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Other: exercise training | Intervention Type: OTHER; Name: breathing retraining; Assigned to Arm(s): Arm 1 | Intervention Type: OTHER; Name: exercise training; Assigned to Arm(s): Arm 1, Arm 2
B: Arm Label: Person-centred care at distance; Type: EXPERIMENTAL; Interventions: Behavioral: Person-centred care at distance | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Person-centred care at distance; Assigned to Arm(s): Person-centred care at distance
C: Intervention Type: BEHAVIORAL; Name: Intermediate care package; Assigned to Arm(s): N/A
D: Arm Label: Control group (Group A); Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Arm Label: Intervention group (Group B); Type: OTHER; Interventions: Other: Home-based telehealth program, Other: Home-based rehabilitation, Other: Usual care | Intervention Type: OTHER; Name: Home-based telehealth program; Assigned to Arm(s): Intervention group (Group B) | Intervention Type: OTHER; Name: Home-based rehabilitation; Assigned to Arm(s): Intervention group (Group B) | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Control group (Group A), Intervention group (Group B)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase III Trial to Compare Epirubicin and Cyclophosphamide (EC) Followed by Docetaxel (T) to Epirubicin and Docetaxel (ET) Followed by Capecitabine (X) as Adjuvant Treatment, Node Positive Breast Cancer Patients
Brief Summary: This is a prospective, randomised phase III trial, to compare the efficacy and safety profiles of two types of adjuvant chemotherapy regimens for human epidermal growth factor receptor 2 (HER2) negative, node positive breast cancer patients.

Control Arm: This includes 4 cycles of EC 90/600 mg/m2 day 1 every 3 weeks, followed by 4 cycles of T 100 mg/m2 day 1 every 3 weeks.

Experimental Arm: This includes 4 cycles of ET 90/75 mg/m2, day 1 every 3 weeks, followed by 4 cycles of capecitabine 1250 mg/m2, twice a day, via oral intake, for 14 days, and then a one-week rest period.

Premenopausal women with hormone receptor positive tumours must receive 5 years of tamoxifen after the end of chemotherapy.

Postmenopausal women with hormone receptor positive tumours can receive tamoxifen or aromatase inhibitors (or both) after the end of chemotherapy.

Patients may receive radiotherapy when clinically indicated.


Options:
A: Arm Label: resp: 4xTAC; Type: EXPERIMENTAL; Interventions: Drug: TAC | Arm Label: resp: 6xTAC; Type: EXPERIMENTAL; Interventions: Drug: TAC | Arm Label: nonResp: 4xTAC; Type: EXPERIMENTAL; Interventions: Drug: TAC | Arm Label: nonResp: 4xNX; Type: EXPERIMENTAL; Interventions: Drug: NX | Intervention Type: DRUG; Name: TAC; Assigned to Arm(s): nonResp: 4xTAC, resp: 4xTAC, resp: 6xTAC | Intervention Type: DRUG; Name: NX; Assigned to Arm(s): nonResp: 4xNX
B: Arm Label: Lapatinib + Vinorelbine; Type: EXPERIMENTAL; Interventions: Drug: Vinorelbine, Drug: Lapatinib | Arm Label: Lapatinib + Capecitabine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lapatinib, Drug: Capecitabine | Intervention Type: DRUG; Name: Vinorelbine; Assigned to Arm(s): Lapatinib + Vinorelbine | Intervention Type: DRUG; Name: Lapatinib; Assigned to Arm(s): Lapatinib + Capecitabine, Lapatinib + Vinorelbine | Intervention Type: DRUG; Name: Capecitabine; Assigned to Arm(s): Lapatinib + Capecitabine
C: Intervention Type: DRUG; Name: capecitabine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: docetaxel; Assigned to Arm(s): N/A
D: Arm Label: Arm A: EC-T; Type: ACTIVE_COMPARATOR; Interventions: Drug: Docetaxel, Drug: Epirubicin, Drug: Cyclophosphamide | Arm Label: Arm B: ET-X; Type: EXPERIMENTAL; Interventions: Drug: Docetaxel, Drug: Capecitabine, Drug: Epirubicin | Intervention Type: DRUG; Name: Docetaxel; Assigned to Arm(s): Arm A: EC-T, Arm B: ET-X | Intervention Type: DRUG; Name: Capecitabine; Assigned to Arm(s): Arm B: ET-X | Intervention Type: DRUG; Name: Epirubicin; Assigned to Arm(s): Arm A: EC-T, Arm B: ET-X | Intervention Type: DRUG; Name: Cyclophosphamide; Assigned to Arm(s): Arm A: EC-T

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multi-centre Randomised Trial of Lay-led Individualised Self-management Education for Adults With Asthma
Brief Summary: Long term conditions often necessitate long term care. In many cases, giving control of their conditions to the patients themselves produces the best outcomes. Such patient education and the acquisition of self-management skills can be time consuming and the evidence suggests that the process is often not undertaken by doctors. Sometimes it is delegated to nursing colleagues, but all health professionals are in short supply. Patients carry credibility as a resource and this project is designed to determine, by means of a multi-centre randomised controlled trial, whether well trained lay educators can deliver training in self-management education to others with asthma, with outcomes equivalent to those achievable by a nurse.


Options:
A: Intervention Type: BEHAVIORAL; Name: Using Parent Mentors to Improve Asthma Care for Urban Minority Children; Assigned to Arm(s): N/A
B: Intervention Type: DEVICE; Name: electronic medication monitoring system; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: parent-adolescent communication and problem-solving skills; Assigned to Arm(s): N/A
C: Arm Label: Nurse group; Type: EXPERIMENTAL; Interventions: Behavioral: Self management education | Arm Label: Lay educator group; Type: EXPERIMENTAL; Interventions: Behavioral: Self management education | Intervention Type: BEHAVIORAL; Name: Self management education; Assigned to Arm(s): Lay educator group, Nurse group
D: Arm Label: community health worker; Type: EXPERIMENTAL; Interventions: Behavioral: community health worker | Arm Label: mailed information; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: mailed information | Intervention Type: BEHAVIORAL; Name: community health worker; Assigned to Arm(s): community health worker | Intervention Type: BEHAVIORAL; Name: mailed information; Assigned to Arm(s): mailed information

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multi-centre Randomised Trial of Lay-led Individualised Self-management Education for Adults With Asthma
Brief Summary: Long term conditions often necessitate long term care. In many cases, giving control of their conditions to the patients themselves produces the best outcomes. Such patient education and the acquisition of self-management skills can be time consuming and the evidence suggests that the process is often not undertaken by doctors. Sometimes it is delegated to nursing colleagues, but all health professionals are in short supply. Patients carry credibility as a resource and this project is designed to determine, by means of a multi-centre randomised controlled trial, whether well trained lay educators can deliver training in self-management education to others with asthma, with outcomes equivalent to those achievable by a nurse.


Options:
A: Arm Label: Nurse group; Type: EXPERIMENTAL; Interventions: Behavioral: Self management education | Arm Label: Lay educator group; Type: EXPERIMENTAL; Interventions: Behavioral: Self management education | Intervention Type: BEHAVIORAL; Name: Self management education; Assigned to Arm(s): Lay educator group, Nurse group
B: Intervention Type: BEHAVIORAL; Name: Shared-Decision Making; Assigned to Arm(s): N/A
C: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mobile phone technology | Intervention Type: BEHAVIORAL; Name: Mobile phone technology; Assigned to Arm(s): 2
D: Intervention Type: BEHAVIORAL; Name: Shared Decision-Making; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Folic Acid Supplementation on Efficacy of Sulfadoxine-pyrimethamine in Pregnant Women in Western Kenya
Brief Summary: The purpose of this study is to determine whether folic acid, which is often routinely given to pregnant women to prevent birth defects and anemia, affects the efficacy of sulfadoxine-pyrimethamine, another drug that is routinely given to pregnant women in highly malarious areas, for prevention of the adverse effects of malaria during pregnancy.


Options:
A: Intervention Type: DRUG; Name: Nutritional supplements; Assigned to Arm(s): N/A
B: Arm Label: 400 micrograms of folic acid; Type: ACTIVE_COMPARATOR; Interventions: Drug: Folic acid: 4 mg versus 0.4 mg per day | Arm Label: 4mg of folic acid; Type: ACTIVE_COMPARATOR; Interventions: Drug: Folic acid: 4 mg versus 0.4 mg per day | Intervention Type: DRUG; Name: Folic acid: 4 mg versus 0.4 mg per day; Assigned to Arm(s): 400 micrograms of folic acid, 4mg of folic acid
C: Intervention Type: DRUG; Name: Sulfadoxine-pyrimethamine/folic acid; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Sulfadoxine-pyrimethamine/placebo; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Folate; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Folic Acid Supplementation on Efficacy of Sulfadoxine-pyrimethamine in Pregnant Women in Western Kenya
Brief Summary: The purpose of this study is to determine whether folic acid, which is often routinely given to pregnant women to prevent birth defects and anemia, affects the efficacy of sulfadoxine-pyrimethamine, another drug that is routinely given to pregnant women in highly malarious areas, for prevention of the adverse effects of malaria during pregnancy.


Options:
A: Intervention Type: DRUG; Name: Sulfadoxine-pyrimethamine/folic acid; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Sulfadoxine-pyrimethamine/placebo; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Folate; Assigned to Arm(s): N/A
C: Arm Label: Folic acid; Type: OTHER; Interventions: Dietary Supplement: Folic acid | Arm Label: Placebo; Type: OTHER; Interventions: Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Folic acid; Assigned to Arm(s): Folic acid | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Ferrous fumarate (iron), Dietary Supplement: folic acid | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: folic acid | Intervention Type: DIETARY_SUPPLEMENT; Name: Ferrous fumarate (iron); Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: folic acid; Assigned to Arm(s): 1, 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of SAVVY and HIV in Nigeria
Brief Summary: Heterosexual contact is now the primary route of transmission for HIV worldwide. This study is a phase 3 trial designed to determine the effectiveness and safety of the 1.0% C31G (SAVVY) vaginal gel for the prevention of male-to-female transmission of HIV among women at high risk.


Options:
A: Intervention Type: DRUG; Name: Carraguard (PC-515); Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: 1.0% C31G SAVVY vaginal gel; Assigned to Arm(s): N/A
C: Arm Label: Deferred screening control group; Type: OTHER; Interventions: Procedure: Screening for chlamydia using self-taken vaginal swabs | Intervention Type: PROCEDURE; Name: Screening for chlamydia using self-taken vaginal swabs; Assigned to Arm(s): Deferred screening control group
D: Intervention Type: DRUG; Name: Cellulose Sulfate Vaginal Gel (Microbicide); Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Skin Cleansing With Chlorhexidine to Improve Nosocomial Infection Risks. (SCCIN Project)
Brief Summary: Patients in the intensive care unit are at risk for many infections because the severity of illness and the procedures necessary to care for them. This study is designed to look at a change in bathing procedure as a method to reduce infections. Currently, patients at John H. Stroger Hospital are cleansed with soap and water. However, preliminary data from a previous study at Rush University Medical Center showed that a chlorhexidine (CHG)-impregnated cloth (2% CHG Antiseptic Cloth system, Sage Products, Inc.) decreased skin bacteria and may lessen bacteria in the blood stream. The 2% CHG Antiseptic Cloth system is a non-irritating, no-rinse, cleansing and moisturizing product that contains 2% chlorhexidine gluconate. The goal of this proposed study is to further evaluate the effectiveness of the 2% CHG Antiseptic Cloth system compared with soap and water in cleansing the skin and preventing bacteria from entering the bloodstream.


Options:
A: Arm Label: Soap bathing; Type: PLACEBO_COMPARATOR; Interventions: Drug: Soap | Arm Label: 2% chlorhexidine wipes; Type: EXPERIMENTAL; Interventions: Drug: 2% chlorhexidine wipe | Intervention Type: DRUG; Name: 2% chlorhexidine wipe; Assigned to Arm(s): 2% chlorhexidine wipes | Intervention Type: DRUG; Name: Soap; Assigned to Arm(s): Soap bathing
B: Intervention Type: PROCEDURE; Name: Bathing with Chlorhexidine Impregnated Washcloths; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: 2% Chlorhexidine gluconate cloth | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: 2% Chlorhexidine gluconate cloth; Assigned to Arm(s): 1
D: Arm Label: chlorhexidine gluconate (CHG); Type: EXPERIMENTAL; Interventions: Drug: 2% chlorhexidine gluconate impregnated cloth | Arm Label: Soap & Water; Type: ACTIVE_COMPARATOR; Interventions: Other: Daily bathing with Bar soap | Intervention Type: DRUG; Name: 2% chlorhexidine gluconate impregnated cloth; Assigned to Arm(s): chlorhexidine gluconate (CHG) | Intervention Type: OTHER; Name: Daily bathing with Bar soap; Assigned to Arm(s): Soap & Water

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An 18-month Randomized Controlled Trial of a Low Glycemic Load Diet
Brief Summary: The primary aim of this study is to compare the effects of an experimental low-glycemic load diet with those of a conventional low-fat diet among obese young adults in an 18-month randomized-controlled trial.


Options:
A: Intervention Type: BEHAVIORAL; Name: low glycemic load diet; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: low fat diet; Assigned to Arm(s): N/A
B: Arm Label: Low glycemic load dietary plan; Type: EXPERIMENTAL; Interventions: Behavioral: Low Glycemic Load Diet versus Low Fat Diet | Arm Label: Low fat diet; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low Glycemic Load Diet versus Low Fat Diet | Intervention Type: BEHAVIORAL; Name: Low Glycemic Load Diet versus Low Fat Diet; Assigned to Arm(s): Low fat diet, Low glycemic load dietary plan
C: Intervention Type: BEHAVIORAL; Name: Low glycemic index diet; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: OTHER; Interventions: Other: Low Glycemic Load Diet, Other: High Glycemic Load Diet | Arm Label: 2; Type: OTHER; Interventions: Other: Low Glycemic Load Diet, Other: High Glycemic Load Diet | Intervention Type: OTHER; Name: Low Glycemic Load Diet; Assigned to Arm(s): 1, 2 | Intervention Type: OTHER; Name: High Glycemic Load Diet; Assigned to Arm(s): 1, 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An 18-month Randomized Controlled Trial of a Low Glycemic Load Diet
Brief Summary: The primary aim of this study is to compare the effects of an experimental low-glycemic load diet with those of a conventional low-fat diet among obese young adults in an 18-month randomized-controlled trial.


Options:
A: Intervention Type: BEHAVIORAL; Name: low glycemic load diet; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: low fat diet; Assigned to Arm(s): N/A
B: Arm Label: Moderately high protein diet; Type: EXPERIMENTAL; Interventions: Behavioral: Moderately high protein diet | Arm Label: Low fat diet; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Low fat diet | Intervention Type: BEHAVIORAL; Name: Moderately high protein diet; Assigned to Arm(s): Moderately high protein diet | Intervention Type: BEHAVIORAL; Name: Low fat diet; Assigned to Arm(s): Low fat diet
C: Arm Label: Low Carbohydrate Diet; Type: EXPERIMENTAL; Interventions: Behavioral: Low Carbohydrate Diet, Behavioral: Mindfulness and Positive Affect Skills | Arm Label: American Diabetes Association Diet; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: American Diabetes Association Diet, Behavioral: Mindfulness and Positive Affect Skills | Intervention Type: BEHAVIORAL; Name: Low Carbohydrate Diet; Assigned to Arm(s): Low Carbohydrate Diet | Intervention Type: BEHAVIORAL; Name: American Diabetes Association Diet; Assigned to Arm(s): American Diabetes Association Diet | Intervention Type: BEHAVIORAL; Name: Mindfulness and Positive Affect Skills; Assigned to Arm(s): American Diabetes Association Diet, Low Carbohydrate Diet
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: low carbohydrate diet | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: low fat diet | Intervention Type: BEHAVIORAL; Name: low carbohydrate diet; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: low fat diet; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Chronic Disease Care With PatientSite
Brief Summary: The overall goal of this randomized, controlled trial is to test whether educational interventions - directed toward empowering patients and delivered via the Beth Israel Deaconess Medical Center (BIDMC's) secure patient Internet portal PatientSite - can improve the outcomes and satisfaction with care of adult primary care patients with 3 common conditions: chronic pain, depression, and progressive difficulty walking.


Options:
A: Intervention Type: BEHAVIORAL; Name: Multi-Source Feedback: including self-assessment & coaching; Assigned to Arm(s): N/A
B: Arm Label: lifestyle counseling tailored; Type: EXPERIMENTAL; Interventions: Behavioral: Tailored counseling | Arm Label: lifestyle counseling motivational; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interview | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Tailored counseling; Assigned to Arm(s): lifestyle counseling tailored | Intervention Type: BEHAVIORAL; Name: Motivational Interview; Assigned to Arm(s): lifestyle counseling motivational
C: Intervention Type: BEHAVIORAL; Name: E-mail coaching to improve patient communication with doctor; Assigned to Arm(s): N/A
D: Arm Label: physician chart reminder; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physician chart reminder | Arm Label: chart reminder, educational mat'ls, FIT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physician chart reminder, Behavioral: chart reminder, educational mat'ls, FIT | Arm Label: CR, ed mat'ls, FIT, phone call; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physician chart reminder, Behavioral: CR,ed mat'ls, FIT, phone call | Intervention Type: BEHAVIORAL; Name: Physician chart reminder; Assigned to Arm(s): CR, ed mat'ls, FIT, phone call, chart reminder, educational mat'ls, FIT, physician chart reminder | Intervention Type: BEHAVIORAL; Name: chart reminder, educational mat'ls, FIT; Assigned to Arm(s): chart reminder, educational mat'ls, FIT | Intervention Type: BEHAVIORAL; Name: CR,ed mat'ls, FIT, phone call; Assigned to Arm(s): CR, ed mat'ls, FIT, phone call

Answer: C